• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转移性结直肠癌患者接受全身化疗后的原发肿瘤反应的内镜评估。

Endoscopic evaluation of primary tumor response in patients with metastatic colorectal cancer treated by systemic chemotherapy.

机构信息

Division of Endoscopy, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi, Suntougun, Shizuoka, 411-8777, Japan.

出版信息

Int J Clin Oncol. 2013 Oct;18(5):864-8. doi: 10.1007/s10147-012-0452-2. Epub 2012 Aug 7.

DOI:10.1007/s10147-012-0452-2
PMID:22865286
Abstract

BACKGROUND

The number of cases of metastatic colorectal cancer treated by chemotherapy without primary tumor resection has recently increased. However, evaluation of primary tumor response by computed tomography is difficult in such cases. In this study, the usefulness of evaluation of primary tumor response to chemotherapy by endoscopy was investigated.

METHODS

This retrospective analysis was performed at the Shizuoka Cancer Center and included 31 patients (88 evaluations) with metastatic colorectal cancer. Computed tomography and endoscopy were performed concomitantly between September 2002 and June 2006. Patients were treated by systemic chemotherapy without prophylactic primary tumor resection. Definitions of primary tumor response were as follows: (1) complete response, confirmed by colorectal biopsy; (2) progressive disease, enlargement of at least one of five tumor parameters; and (3) neither (1) nor (2). Computed tomography was performed to evaluate primary tumor response according to the Response Evaluation Criteria in Solid Tumors and to identify colorectal stenosis secondary to primary tumors.

RESULTS

The rate of concordance between endoscopy and computed tomography for evaluation of primary tumor response was 75%. Colorectal stenosis was detected 14 times by endoscopy (9 cases) and 3 times by computed tomography (3 cases). Of the 7 patients in whom surgery was required, 6 exhibited stenotic symptoms before endoscopic detection.

CONCLUSIONS

With regard to primary tumor response evaluation, a high concordance rate was observed between endoscopy and computed tomography, although endoscopic evaluation appeared more sensitive in detecting colorectal stenosis requiring surgical treatment.

摘要

背景

最近,未经原发肿瘤切除而接受化疗治疗转移性结直肠癌的病例数量有所增加。然而,在这种情况下,通过计算机断层扫描评估原发肿瘤的反应较为困难。在本研究中,我们探讨了通过内镜评估化疗后原发肿瘤反应的有效性。

方法

本回顾性分析在静冈癌症中心进行,纳入了 31 例(88 次评估)转移性结直肠癌患者。2002 年 9 月至 2006 年 6 月期间同时进行计算机断层扫描和内镜检查。患者接受全身化疗,未进行预防性原发肿瘤切除。原发肿瘤反应的定义如下:(1)完全缓解,通过直肠活检证实;(2)进展性疾病,至少有五个肿瘤参数中的一个增大;(3)既不属于(1)也不属于(2)。根据实体瘤反应评估标准对计算机断层扫描进行评估,以确定是否存在原发性肿瘤引起的结直肠狭窄。

结果

内镜和计算机断层扫描评估原发肿瘤反应的一致性率为 75%。内镜检查发现结直肠狭窄 14 次(9 例),计算机断层扫描发现 3 次(3 例)。在需要手术的 7 例患者中,6 例在内镜检测到狭窄症状之前就出现了该症状。

结论

在评估原发肿瘤反应方面,内镜和计算机断层扫描的一致性较高,但内镜评估在检测需要手术治疗的结直肠狭窄方面更为敏感。

相似文献

1
Endoscopic evaluation of primary tumor response in patients with metastatic colorectal cancer treated by systemic chemotherapy.转移性结直肠癌患者接受全身化疗后的原发肿瘤反应的内镜评估。
Int J Clin Oncol. 2013 Oct;18(5):864-8. doi: 10.1007/s10147-012-0452-2. Epub 2012 Aug 7.
2
Risk factors for the requirement of surgical or endoscopic interventions during chemotherapy in patients with uncomplicated colorectal cancer and unresectable synchronous metastases.单纯性结直肠癌和不可切除性同步转移患者化疗期间手术或内镜干预需求的危险因素。
J Surg Oncol. 2014 Dec;110(7):839-44. doi: 10.1002/jso.23725. Epub 2014 Jul 18.
3
Response of the primary tumor in symptomatic and asymptomatic stage IV colorectal cancer to combined interventional endoscopy and palliative chemotherapy.有症状和无症状的IV期结直肠癌原发肿瘤对介入性内镜检查与姑息化疗联合治疗的反应。
BMC Cancer. 2009 Jul 1;9:218. doi: 10.1186/1471-2407-9-218.
4
[Retrospective investigation of patients receiving additional surgery after endoscopic non-curative resection for early colorectal cancer].[早期结直肠癌内镜下非根治性切除术后接受额外手术患者的回顾性调查]
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 May 25;23(5):486-491. doi: 10.3760/cma.j.cn.441530-20190612-00239.
5
Colorectal carcinoma in children.儿童结直肠癌
J Pediatr Surg. 1999 Oct;34(10):1499-504. doi: 10.1016/s0022-3468(99)90112-4.
6
Diagnostic utility of staging abdominal computerized tomography and repeat endoscopy in detecting localization errors at initial endoscopy in colorectal cancer.结直肠癌初始内镜定位错误时分期腹部计算机断层扫描和重复内镜检查的诊断效用。
Surg Endosc. 2018 Jul;32(7):3303-3310. doi: 10.1007/s00464-018-6051-1. Epub 2018 Jan 23.
7
Outcome of salvage surgery for colorectal cancer initially treated by upfront endoscopic therapy.最初采用 upfront 内镜治疗的结直肠癌挽救性手术的结果
Surgery. 2016 Mar;159(3):713-20. doi: 10.1016/j.surg.2015.09.008. Epub 2015 Oct 21.
8
[Treatment of colorectal cancer with unresectable metastasis with chemotherapy without primary tumor resection: analysis of tumor-related complications].[对不可切除转移性结直肠癌不进行原发肿瘤切除而采用化疗的治疗:肿瘤相关并发症分析]
Cir Esp. 2014 Jan;92(1):30-7. doi: 10.1016/j.ciresp.2013.04.015. Epub 2013 Oct 28.
9
Nonsurgical treatment of the primary tumor in four consecutive cases of metastasized colorectal carcinoma.四例转移性结直肠癌患者原发性肿瘤的非手术治疗
Endoscopy. 2005 Dec;37(12):1232-6. doi: 10.1055/s-2005-870225.
10
The efficacy of diffusion-weighted imaging for the detection of colorectal cancer.扩散加权成像在检测结直肠癌中的效能。
Hepatogastroenterology. 2009 Jan-Feb;56(89):128-32.

引用本文的文献

1
Evaluating the predictive value of endoscopic findings for residual colorectal cancer following neoadjuvant combination immunotherapy.评估新辅助联合免疫治疗后内镜检查结果对结直肠癌残留病灶的预测价值。
World J Gastrointest Surg. 2025 Jan 27;17(1):98263. doi: 10.4240/wjgs.v17.i1.98263.
2
Molecular imaging in gastroenterology.胃肠病学中的分子影像学。
Nat Rev Gastroenterol Hepatol. 2013 Dec;10(12):704-12. doi: 10.1038/nrgastro.2013.125. Epub 2013 Jul 16.

本文引用的文献

1
Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment.同步性IV期结直肠癌患者接受联合化疗而非手术作为初始治疗时原发性肿瘤的转归
J Clin Oncol. 2009 Jul 10;27(20):3379-84. doi: 10.1200/JCO.2008.20.9817. Epub 2009 Jun 1.
2
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).实体瘤新的疗效评价标准:修订的RECIST指南(第1.1版)
Eur J Cancer. 2009 Jan;45(2):228-47. doi: 10.1016/j.ejca.2008.10.026.
3
Management of patients with asymptomatic colorectal cancer and synchronous irresectable metastases.
无症状性结直肠癌合并同步不可切除转移患者的管理
Ann Oncol. 2008 Nov;19(11):1829-35. doi: 10.1093/annonc/mdn398. Epub 2008 Jul 28.
4
Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.贝伐单抗联合奥沙利铂为基础的化疗作为转移性结直肠癌的一线治疗:一项随机III期研究。
J Clin Oncol. 2008 Apr 20;26(12):2013-9. doi: 10.1200/JCO.2007.14.9930.
5
Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C Study.伊立替康联合持续静脉输注、大剂量推注或口服氟嘧啶用于转移性结直肠癌一线治疗的随机对照试验:BICC-C研究结果
J Clin Oncol. 2007 Oct 20;25(30):4779-86. doi: 10.1200/JCO.2007.11.3357.
6
Palliative resection of colorectal cancer: does it prolong survival?结直肠癌的姑息性切除:它能延长生存期吗?
Ann Surg Oncol. 2007 Sep;14(9):2567-76. doi: 10.1245/s10434-007-9444-2. Epub 2007 May 31.
7
Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases.结直肠癌合并同时性不可切除肝转移患者的治疗策略
Br J Surg. 2005 Sep;92(9):1155-60. doi: 10.1002/bjs.5060.
8
Use of surgery among elderly patients with stage IV colorectal cancer.老年IV期结直肠癌患者的手术应用。
J Clin Oncol. 2004 Sep 1;22(17):3475-84. doi: 10.1200/JCO.2004.10.218.
9
FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study.晚期结直肠癌中FOLFIRI序贯FOLFOX6或相反顺序:一项GERCOR随机研究
J Clin Oncol. 2004 Jan 15;22(2):229-37. doi: 10.1200/JCO.2004.05.113. Epub 2003 Dec 2.
10
Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases.不可切除的原发性结直肠癌和同步转移患者化疗后的肠道并发症。
Gut. 2003 Apr;52(4):568-73. doi: 10.1136/gut.52.4.568.